Desensitization: Overcoming the Immunologic Barriers to Transplantation
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Desensitization: Overcoming the Immunologic Barriers to Transplantation
Authors
Keywords
-
Journal
Journal of Immunology Research
Volume 2017, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2017-01-04
DOI
10.1155/2017/6804678
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection
- (2017) Stanley C. Jordan et al. TRANSPLANTATION
- 32 Doses of Bortezomib for Desensitization Is Not Well Tolerated and Is Associated With Only Modest Reductions in Anti-HLA Antibody
- (2017) Manuel A. Moreno Gonzales et al. TRANSPLANTATION
- Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study
- (2016) R. A. Montgomery et al. AMERICAN JOURNAL OF TRANSPLANTATION
- C1 Inhibitor in Acute Antibody-Mediated Rejection Nonresponsive to Conventional Therapy in Kidney Transplant Recipients: A Pilot Study
- (2016) D. Viglietti et al. AMERICAN JOURNAL OF TRANSPLANTATION
- IVIG in autoimmune disease — Potential next generation biologics
- (2016) Adrian W. Zuercher et al. AUTOIMMUNITY REVIEWS
- Desensitization Using Bortezomib and High-dose Immunoglobulin Increases Rate of Deceased Donor Kidney Transplantation
- (2016) Jong Cheol Jeong et al. MEDICINE
- Bortezomib for refractory acute antibody-mediated rejection in kidney transplant recipients: A single-centre case series
- (2016) Erika De Sousa-Amorim et al. NEPHROLOGY
- Belatacept and Long-Term Outcomes in Kidney Transplantation
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors
- (2016) Babak J. Orandi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunological characterization of de novo and recall alloantibody suppression by CTLA4Ig in a mouse model of allosensitization
- (2016) Irene Kim et al. TRANSPLANT IMMUNOLOGY
- Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximab
- (2016) Joseph Kahwaji et al. TRANSPLANT INTERNATIONAL
- Presentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney Transplantation
- (2015) B. J. Orandi et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Rituximab as Induction Therapy After Renal Transplantation: A Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety
- (2015) M. W. F. van den Hoogen et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Positive Crossmatch Kidney Transplant Recipients Treated With Eculizumab: Outcomes Beyond 1 Year
- (2015) L. D. Cornell et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Randomized phase 2 study of obinutuzumab monotherapy in symptomatic, previously untreated chronic lymphocytic leukemia
- (2015) J. C. Byrd et al. BLOOD
- Kidney transplantation in highly sensitized patients
- (2015) Stanley C. Jordan et al. BRITISH MEDICAL BULLETIN
- Intravenous immunoglobulin as clinical immune-modulating therapy
- (2015) Laurent Gilardin et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Interleukin-6 as a Therapeutic Target
- (2015) J.-F. Rossi et al. CLINICAL CANCER RESEARCH
- Achieving incompatible transplantation through desensitization: current perspectives and future directions
- (2015) Stanley C Jordan et al. Immunotherapy
- Cutting Edge: Circulating Plasmablasts Induce the Differentiation of Human T Follicular Helper Cells via IL-6 Production
- (2015) Konstantia-Maria Chavele et al. JOURNAL OF IMMUNOLOGY
- IL-6 Trans-Signaling Drives Murine Crescentic GN
- (2015) G. S. Braun et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation
- (2015) Annette M. Jackson et al. KIDNEY INTERNATIONAL
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity
- (2015) Nathaniel Washburn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- JC polyomavirus viremia and progressive multifocal leukoencephalopathy in human leukocyte antigen-sensitized kidney transplant recipients desensitized with intravenous immunoglobulin and rituximab
- (2015) M. Toyoda et al. Transplant Infectious Disease
- Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization
- (2015) Ashley A. Vo et al. TRANSPLANTATION
- Hypoxia and Complement-and-Coagulation Pathways in the Deceased Organ Donor as the Major Target for Intervention to Improve Renal Allograft Outcome
- (2015) Jeffrey Damman et al. TRANSPLANTATION
- A Phase I/II Trial of the Interleukin-6 Receptor–Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients
- (2015) Ashley A. Vo et al. TRANSPLANTATION
- A Phase I/II Placebo-Controlled Trial of C1-Inhibitor for Prevention of Antibody-Mediated Rejection in HLA Sensitized Patients
- (2015) Ashley A. Vo et al. TRANSPLANTATION
- Obinutuzumab (GA101) for the Treatment of Chronic Lymphocytic Leukemia and Other B-Cell Non-Hodgkin's Lymphomas: A Glycoengineered Type II CD20 Antibody
- (2015) Valentin Goede et al. Oncology Research and Treatment
- Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction
- (2015) Byung Ha Chung et al. PLoS One
- Center-Defined Unacceptable HLA Antigens Facilitate Transplants for Sensitized Patients in a Multi-Center Kidney Exchange Program
- (2014) L. A. Baxter-Lowe et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Quantifying the Risk of Incompatible Kidney Transplantation: A Multicenter Study
- (2014) B. J. Orandi et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Prospective Iterative Trial of Proteasome Inhibitor-Based Desensitization
- (2014) E. S. Woodle et al. AMERICAN JOURNAL OF TRANSPLANTATION
- U.S. Food and Drug Administration Approval: Obinutuzumab in Combination with Chlorambucil for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia
- (2014) H.-Z. Lee et al. CLINICAL CANCER RESEARCH
- Bortezomib in multiple myeloma: systematic review and clinical considerations
- (2014) T.C. Kouroukis et al. Current Oncology
- Complement as a multifaceted modulator of kidney transplant injury
- (2014) Paolo Cravedi et al. JOURNAL OF CLINICAL INVESTIGATION
- Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial
- (2014) Glen A Kennedy et al. LANCET ONCOLOGY
- Antibody-mediated rejection despite inhibition of terminal complement
- (2014) Andrew Bentall et al. TRANSPLANT INTERNATIONAL
- Benefits of Rituximab Combined With Intravenous Immunoglobulin for Desensitization in Kidney Transplant Recipients
- (2014) Ashley A. Vo et al. TRANSPLANTATION
- Anti–Interleukin 6 Receptor Antibodies Attenuate Antibody Recall Responses in a Mouse Model of Allosensitization
- (2014) Irene Kim et al. TRANSPLANTATION
- IL-6 in Inflammation, Immunity, and Disease
- (2014) T. Tanaka et al. Cold Spring Harbor Perspectives in Biology
- Carfilzomib: A Second-Generation Proteasome Inhibitor for the Treatment of Relapsed and Refractory Multiple Myeloma
- (2013) Jennifer L Thompson ANNALS OF PHARMACOTHERAPY
- Kidney paired donation in the presence of donor-specific antibodies
- (2013) Jeremy M. Blumberg et al. KIDNEY INTERNATIONAL
- How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy
- (2013) Georg Schett et al. NATURE MEDICINE
- Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
- (2013) Alexandre Loupy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy, Outcomes, and Cost-Effectiveness of Desensitization Using IVIG and Rituximab
- (2013) Ashley A. Vo et al. TRANSPLANTATION
- Rituximab Prevents an Anamnestic Response in Patients With Cryptic Sensitization to HLA
- (2013) Andrea A. Zachary et al. TRANSPLANTATION
- Analysis of Anti-HLA Antibodies in Sensitized Kidney Transplant Candidates Subjected to Desensitization with Intravenous Immunoglobulin and Rituximab
- (2013) Andrew L. Lobashevsky et al. TRANSPLANTATION
- Polyomavirus BK Viremia in Kidney Transplant Recipients After Desensitization With IVIG and Rituximab
- (2013) Debora Barbosa et al. TRANSPLANTATION
- Desensitization Combined With Paired Exchange Leads to Successful Transplantation in Highly Sensitized Kidney Transplant Recipients: Strategy and Report of Five Cases
- (2013) J.M. Yabu et al. TRANSPLANTATION PROCEEDINGS
- Belimumab: Review of Use in Systemic Lupus Erythematosus
- (2012) Eric G. Boyce et al. CLINICAL THERAPEUTICS
- The impact of donor-specific anti-HLA antibodies on late kidney allograft failure
- (2012) Alexandre Loupy et al. Nature Reviews Nephrology
- Lack of Effect in Desensitization With Intravenous Immunoglobulin and Rituximab in Highly Sensitized Patients
- (2012) Kwaku Marfo et al. TRANSPLANTATION
- Chronic Antibody-Mediated Rejection Is Reduced by Targeting B-Cell Immunity During an Introductory Period
- (2011) N. Kohei et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Summary of FDA Antibody-Mediated Rejection Workshop
- (2011) P. Archdeacon et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence
- (2011) J. Sellarés et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Infectious Complications in Kidney-Transplant Recipients Desensitized with Rituximab and Intravenous Immunoglobulin
- (2011) J. Kahwaji et al. Clinical Journal of the American Society of Nephrology
- Regulation of immunity and inflammation by intravenous immunoglobulin: relevance to solid organ transplantation
- (2011) Stanley C Jordan et al. Expert Review of Clinical Immunology
- Neutralizing IL-6 Reduces Human Arterial Allograft Rejection by Allowing Emergence of CD161+ CD4+ Regulatory T Cells
- (2011) B. Fogal et al. JOURNAL OF IMMUNOLOGY
- Desensitization in HLA-Incompatible Kidney Recipients and Survival
- (2011) Robert A. Montgomery et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic alloantibody mediated rejection
- (2011) R. Neal Smith et al. SEMINARS IN IMMUNOLOGY
- Antibody Testing Strategies for Deceased Donor Kidney Transplantation After Immunomodulatory Therapy
- (2011) Chih-Hung Lai et al. TRANSPLANTATION
- Human Leukocyte Antigen Antibody-Incompatible Renal Transplantation: Excellent Medium-Term Outcomes With Negative Cytotoxic Crossmatch
- (2011) Robert Higgins et al. TRANSPLANTATION
- The complement system
- (2010) J. Vidya Sarma et al. CELL AND TISSUE RESEARCH
- Inhibition of B cell-mediated antigen presentation by intravenous immunoglobulins (IVIg)
- (2010) Dominic Paquin Proulx et al. CLINICAL IMMUNOLOGY
- Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation
- (2010) C. Lefaucheur et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Combined Posttransplant Prophylactic IVIg/Anti-CD 20/Plasmapheresis in Kidney Recipients With Preformed Donor-Specific Antibodies: A Pilot Study
- (2010) Alexandre Loupy et al. TRANSPLANTATION
- Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney Transplantation
- (2010) Ashley A. Vo et al. TRANSPLANTATION
- Profile of belatacept and its potential role in prevention of graft rejection following renal transplantation
- (2010) Karl Womer et al. Drug Design Development and Therapy
- De NovoDonor-Specific Antibody at the Time of Kidney Transplant Biopsy Associates with Microvascular Pathology and Late Graft Failure
- (2009) L. G. Hidalgo et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure
- (2009) G. Einecke et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Intravenous Immunoglobulin a Natural Regulator of Immunity and Inflammation
- (2009) Stanley C. Jordan et al. TRANSPLANTATION
- Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation
- (2008) Ashley A. Vo et al. NEW ENGLAND JOURNAL OF MEDICINE
- IdeS: A Bacterial Proteolytic Enzyme with Therapeutic Potential
- (2008) Björn P. Johansson et al. PLoS One
- Acceptable Donor-Specific Antibody Levels Allowing for Successful Deceased and Living Donor Kidney Transplantation After Desensitization Therapy
- (2008) Nancy L. Reinsmoen et al. TRANSPLANTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started